All Stories

  1. Diagnostic utility of cerebrospinal fluid α-synuclein in Parkinson's disease: A systematic review and meta-analysis

    Article • Movement Disorders, September 2017, Wiley

    Dr Iosief Abraha, Paolo Eusebi, Lucilla Parnetti, david giannandrea

  2. Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients

    Article • Movement Disorders, August 2017, Wiley

    Dr Nicola Tambasco, Paolo Eusebi, Lucilla Parnetti, Dr. Nicola Tambasco

  3. Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease

    Article • Expert Review of Molecular Diagnostics, June 2017, Taylor & Francis

    Paolo Eusebi, Lucilla Parnetti

  4. Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression

    Article • Movement Disorders, October 2016, Wiley

    Paolo Eusebi, Lucilla Parnetti

  5. Cerebrospinal fluid biomarkers in Alzheimer's and Parkinson's diseases-From pathophysiology to clinical practice

    Article • Movement Disorders, May 2016, Wiley

    Paolo Eusebi, Lucilla Parnetti

  6. Value of cerebrospinal fluid α-synuclein species as biomarker in Parkinson's diagnosis and prognosis

    Article • Biomarkers in Medicine, January 2016, Future Medicine

    Paolo Eusebi